Vectors Research Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Hold
3,851
0.26% 84
2026
Q1
$941K Buy
3,851
+57
+2% +$13.3K 0.28% 80
2025
Q4
$785K Hold
3,794
0.24% 81
2025
Q3
$703K Buy
3,794
+217
+6% +$37.2K 0.22% 81
2025
Q2
$546K Sell
3,577
-613
-15% -$94.2K 0.19% 87
2025
Q1
$695K Sell
4,190
-70
-2% -$11K 0.24% 78
2024
Q4
$616K Sell
4,260
-1,248
-23% -$193K 0.21% 85
2024
Q3
$893K Sell
5,508
-251
-4% -$40K 0.27% 85
2024
Q2
$842K Buy
5,759
+95
+2% +$14.1K 0.26% 84
2024
Q1
$896K Sell
5,664
-211
-4% -$33.6K 0.25% 86
2023
Q4
$924K Sell
5,875
-40
-0.7% -$6.13K 0.26% 80
2023
Q3
$902K Sell
5,915
-815
-12% -$134K 0.29% 71
2023
Q2
$1.11M Buy
6,730
+205
+3% +$33.1K 0.32% 71
2023
Q1
$1.01M Sell
6,525
-262
-4% -$42.3K 0.26% 74
2022
Q4
$1.2M Buy
6,787
+146
+2% +$25.2K 0.31% 72
2022
Q3
$1.08M Sell
6,641
-143
-2% -$24.2K 0.31% 72
2022
Q2
$1.2M Sell
6,784
-544
-7% -$96.9K 0.31% 78
2022
Q1
$1.3M Sell
7,328
-2,067
-22% -$352K 0.28% 78
2021
Q4
$1.61M Buy
9,395
+422
+5% +$69.1K 0.34% 70
2021
Q3
$1.45M Sell
8,973
-498
-5% -$85K 0.34% 65
2021
Q2
$1.56M Sell
9,471
-144
-1% -$23.8K 0.4% 58
2021
Q1
$1.58M Sell
9,615
-497
-5% -$80.4K 0.44% 54
2020
Q4
$1.59M Buy
10,112
+2,641
+35% +$390K 0.49% 48
2020
Q3
$1.1M Sell
7,471
-771
-9% -$114K 0.4% 62
2020
Q2
$1.16M Buy
8,242
+2
+0% +$291 0.46% 55
2020
Q1
$1.08M Sell
8,240
-883
-10% -$125K 0.51% 50
2019
Q4
$1.33M Buy
9,123
+1
+0% +$136 0.54% 46
2019
Q3
$1.18M Sell
9,122
-219
-2% -$28.9K 0.58% 39
2019
Q2
$1.3M Sell
9,341
-296
-3% -$41K 0.7% 32
2019
Q1
$1.35M Buy
9,637
+3,086
+47% +$413K 0.76% 31
2018
Q4
$845K Sell
6,551
-2,989
-31% -$417K 0.4% 60
2018
Q3
$1.16M Buy
+9,540
New +$1.27M 0.71% 32

Other funds holding JNJ

Vectors Research Management's JNJ Position: Q2 2026 in Review

Vectors Research Management held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 3,851 shares worth $978K. The position accounts for 0.26% of the portfolio, ranked #84.

Vectors Research Management first reported a position in JNJ in Q3 2018 and has held it in 32 quarters since. The position peaked at $1.61M in Q4 2021. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Vectors Research Management held 3,851 shares of Johnson & Johnson worth $978K as of Q2 2026.
  • Vectors Research Management left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.26% of Vectors Research Management's portfolio in Q2 2026, its #84 holding.
  • Vectors Research Management first reported a position in Johnson & Johnson in Q3 2018 and has held it in 32 quarters since.
  • Vectors Research Management's Johnson & Johnson position peaked at $1.61M in Q4 2021.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Vectors Research Management's 13F filing for Q2 2026, filed 29 Jul 2026.